Is surveillance endoscopy recommended for individuals with a second-degree relative with gastric cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Surveillance Endoscopy for Second-Degree Relatives with Gastric Cancer

Surveillance endoscopy is not routinely recommended for individuals who only have a second-degree relative with gastric cancer, unless additional risk factors are present. 1

Risk Stratification for Gastric Cancer Surveillance

The British Society of Gastroenterology guidelines and other major gastroenterology societies focus surveillance recommendations primarily on:

  1. First-degree relatives with gastric cancer (not second-degree)
  2. Presence of premalignant conditions (extensive gastric atrophy or intestinal metaplasia)
  3. Hereditary cancer syndromes with specific genetic mutations

When to Consider Surveillance for Second-Degree Relatives

While having only a second-degree relative with gastric cancer is not sufficient to warrant routine surveillance, endoscopic screening may be considered if additional risk factors are present:

  • Multiple risk factors including:
    • H. pylori infection (current or past)
    • Early-generation immigrant from high-incidence regions (Eastern Europe, Andean Latin America, East Asia)
    • Non-white racial/ethnic groups from high-incidence regions
    • Age ≥45 years 1

Evidence-Based Approach

The British Society of Gastroenterology guidelines specifically recommend:

  • Surveillance endoscopy every 3 years for patients with extensive gastric atrophy or intestinal metaplasia affecting both antrum and body 1
  • No surveillance for those with limited gastric atrophy/intestinal metaplasia (antrum only) unless additional risk factors like strong family history or persistent H. pylori infection 1

For individuals with hereditary cancer syndromes:

  • Specific surveillance protocols exist for conditions like Hereditary Diffuse Gastric Cancer (HDGC) with CDH1 mutations 1
  • Familial Intestinal Gastric Cancer (FIGC) has less robust recommendations but may warrant consideration in families with clustering of intestinal-type gastric cancer 1

Practical Algorithm for Second-Degree Relatives

  1. Assess additional risk factors:

    • H. pylori status (test and eradicate if positive)
    • Geographic origin/ethnicity (high vs. low risk regions)
    • Personal history of premalignant gastric conditions
  2. If no additional risk factors: Routine surveillance not recommended

  3. If additional risk factors present:

    • Consider baseline endoscopy at age 45 or 10 years before the youngest affected relative's diagnosis 2
    • If baseline endoscopy normal: No routine surveillance needed
    • If premalignant conditions found: Follow standard surveillance protocols based on findings

Important Considerations

  • H. pylori eradication is the most important preventive strategy for those with family history of gastric cancer 3
  • The synergistic effect of H. pylori infection and family history significantly increases gastric cancer risk 2
  • Early H. pylori eradication (ideally in 20s-30s) may prevent progression to intestinal metaplasia 3

Common Pitfalls to Avoid

  • Over-surveillance: Performing unnecessary endoscopies in low-risk individuals wastes resources and exposes patients to procedural risks
  • Under-surveillance: Missing high-risk individuals who have multiple risk factors beyond just a second-degree relative
  • Neglecting H. pylori testing: All individuals with family history of gastric cancer should be tested and treated for H. pylori infection

In summary, having only a second-degree relative with gastric cancer is not sufficient to warrant routine endoscopic surveillance, but should prompt assessment for additional risk factors that might justify screening.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Gastric cancer and family history.

The Korean journal of internal medicine, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.